carbamates has been researched along with Cystic Fibrosis of Pancreas in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin and glucose levels in response to premeal insulin lispro or repaglinide were evaluated in adult patients with cystic fibrosis-related diabetes (CFRD) without fasting hyperglycemia." | 7.71 | Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. ( Milla, C; Moran, A; Phillips, J, 2001) |
| " Four trials (200 participants) are included: one short-term single-center trial (n = 7) comparing insulin with oral repaglinide and no medication in people with cystic fibrosis-related diabetes and normal fasting glucose; one long-term multicenter trial (n = 100, 74 of whom had cystic fibrosis-related diabetes) comparing insulin with oral repaglinide and placebo; one long-term multicenter trial (n = 73) comparing insulin with oral repaglinide; and one 12-week single-center trial (n = 20) comparing the long-acting insulin glargine to short-term neutral protamine Hagedorn insulin." | 4.93 | Insulin and oral agents for managing cystic fibrosis-related diabetes. ( Onady, GM; Stolfi, A, 2016) |
| "Insulin and glucose levels in response to premeal insulin lispro or repaglinide were evaluated in adult patients with cystic fibrosis-related diabetes (CFRD) without fasting hyperglycemia." | 3.71 | Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. ( Milla, C; Moran, A; Phillips, J, 2001) |
| " In another study using the same dosage regimen, amelubant appeared to be safe and well tolerated." | 2.43 | Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. ( Schmitt-Grohé, S; Zielen, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Onady, GM | 2 |
| Stolfi, A | 2 |
| Giacomini, D | 1 |
| Martelli, G | 1 |
| Piccichè, M | 1 |
| Calaresu, E | 1 |
| Cocuzza, CE | 1 |
| Musumeci, R | 1 |
| Ballmann, M | 2 |
| Hubert, D | 2 |
| Assael, BM | 2 |
| Staab, D | 1 |
| Hebestreit, A | 1 |
| Naehrlich, L | 1 |
| Nickolay, T | 1 |
| Prinz, N | 1 |
| Holl, RW | 2 |
| Döring, G | 2 |
| Bragonzi, A | 1 |
| Paroni, M | 1 |
| Aktürk, FF | 1 |
| Cigana, C | 1 |
| Schmidt, A | 1 |
| Gilpin, D | 1 |
| Heyder, S | 1 |
| Born, T | 1 |
| Smaczny, C | 1 |
| Kohlhäufl, M | 1 |
| Wagner, TO | 1 |
| Loebinger, MR | 1 |
| Bilton, D | 1 |
| Tunney, MM | 1 |
| Elborn, JS | 1 |
| Pier, GB | 1 |
| Konstan, MW | 2 |
| Ulrich, M | 1 |
| Heltshe, SL | 1 |
| Lands, LC | 1 |
| Hilliard, KA | 1 |
| Koker, P | 1 |
| Bhattacharya, S | 1 |
| Staab, A | 1 |
| Hamilton, A | 1 |
| Kronfeld, K | 1 |
| Honer, M | 1 |
| Schmitt-Grohé, S | 1 |
| Zielen, S | 1 |
| Moran, A | 1 |
| Phillips, J | 1 |
| Milla, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open Randomised Prospective Comparative Multi-centre Intervention Study of Patients With Cystic Fibrosis and Early Diagnosed Diabetes Mellitus[NCT00662714] | Phase 3 | 73 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for carbamates and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Drug treatments for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Bias; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Fasting; | 2020 |
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Humans; Hyperglycemia; Hypogly | 2016 |
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Topics: Adolescent; Amidines; Asthma; Bronchial Hyperreactivity; Carbamates; Child; Child, Preschool; Clinic | 2005 |
3 trials available for carbamates and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Carbamates; Child; Cystic Fibrosis; Diabetes Mellitus, | 2018 |
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Topics: Adolescent; Adult; Amidines; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Carbamates; Chi | 2014 |
Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Topics: Adolescent; Algorithms; Carbamates; Child; Cystic Fibrosis; Diabetes Mellitus; Early Diagnosis; Huma | 2014 |
3 other studies available for carbamates and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Design and Synthesis of 4-Alkylidene-β-lactams: Benzyl- and Phenethyl-carbamates as Key Fragments to Switch on Antibacterial Activity.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbamates; Cystic Fibrosis; Drug Design; Gram-Negative Bacteri | 2017 |
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.
Topics: Adult; Amidines; Animals; Anti-Inflammatory Agents; Bacteremia; Carbamates; Cystic Fibrosis; Disease | 2014 |
Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
Topics: Adult; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Female; Food; Humans; Hypoglyc | 2001 |